The molecular mechanisms that control cardiomyocyte proliferation and growth are fundamental to normalheart development, and dysregulation of these processes contributes to congenital and adult cardiacdisease. During prenatal development, the heart grows mainly through hyperplastic growth of differentiatedcardiomyocytes, and increased sarcomeric architecture is apparent as development proceeds. Postnatally,cardiomyocytes withdraw from the cell cycle, and heart growth is due largely to cardiomyocyte hypertrophy.The regulatory mechanisms that control differential regulation of proliferation and hypertrophy duringdevelopment and that control perinatal cardiomyocyte cell cycle withdrawal are not completely known. Inskeletal and smooth muscle, FoxO transcription factors antagonized by Akt phosphorylation directly regulateexpression of genes that inhibit cell cycle progression and promote muscle atrophy. The functions of the Aktsignaling pathway and FoxO transcription factors in the developing heart will be examined in embryonic,fetal, neonatal and adult cardiomyocytes in cell culture and in genetically manipulated mouse models. Thehypothesis is that Akt-mediated inactivation of FoxO transcription factors promotes cardiomyocyteproliferation and regulates heart growth during development. Preliminary studies demonstrate that FoxO areexpressed in the developing heart, and treatment of fetal cardiomyocytes with IGF-I leads to increasedproliferation and FoxO1 phosphorylation through a PI3K-dependent mechanism.
Aim 1. Determine if FoxO1or FoxOS regulate proliferation and maturation downstream PI3K/AKT signaling in cultured embryonic, fetalor neonatal cardiomyocytes.
Aim 2. Determine if FoxO1 regulates differential growth and hypertrophy of thedeveloping myocardium in vivo. The immediate goal is to determine if FoxO transcription factors regulated byAkt phosphorylation control cardiomyocyte proliferation and cell size (hypertrophy) at specific stages ofcardiomyocyte development and maturation. The long term goal is to define signal transductionmechanisms underlying growth, differentiation and maturation of the developing and adult myocardium.These studies are designed to reveal developmentally important growth control mechanisms of cardiacmuscle that could be exploited in the treatment of congenital or adult heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL069779-06A1
Application #
7429206
Study Section
Special Emphasis Panel (ZHL1-PPG-D (O2))
Project Start
2007-12-01
Project End
2012-11-30
Budget Start
2007-12-01
Budget End
2008-12-31
Support Year
6
Fiscal Year
2008
Total Cost
$328,982
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Singh, Sonia R; Robbins, Jeffrey (2018) Desmin and Cardiac Disease: An Unfolding Story. Circ Res 122:1324-1326
Lowey, Susan; Bretton, Vera; Joel, Peteranne B et al. (2018) Hypertrophic cardiomyopathy R403Q mutation in rabbit ?-myosin reduces contractile function at the molecular and myofibrillar levels. Proc Natl Acad Sci U S A 115:11238-11243
Valiente-Alandi, Iñigo; Potter, Sarah J; Salvador, Ane M et al. (2018) Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure. Circulation 138:1236-1252
Meng, Qinghang; Bhandary, Bidur; Bhuiyan, Md Shenuarin et al. (2018) Myofibroblast-Specific TGF? Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy. Circ Res 123:1285-1297
Robbins, Jeffrey (2017) Oliver Smithies, DPhil: 1925-2017. Circ Res 120:1535-1536
Tallquist, Michelle D; Molkentin, Jeffery D (2017) Redefining the identity of cardiac fibroblasts. Nat Rev Cardiol 14:484-491
Travers, Joshua G; Kamal, Fadia A; Valiente-Alandi, Iñigo et al. (2017) Pharmacological and Activated Fibroblast Targeting of G??-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression. J Am Coll Cardiol 70:958-971
Schafer, Allison E; Blaxall, Burns C (2017) G Protein Coupled Receptor-mediated Transactivation of Extracellular Proteases. J Cardiovasc Pharmacol 70:10-15
Singh, Sonia R; Zech, Antonia T L; Geertz, Birgit et al. (2017) Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3-Targeted Knockin Mice. Circ Heart Fail 10:
Xiang, Fu-Li; Fang, Ming; Yutzey, Katherine E (2017) Loss of ?-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice. Nat Commun 8:712

Showing the most recent 10 out of 131 publications